Hedge Fund - Palo Alto Investors

William Leland Edwards' fund, Palo Alto Investors, just reported cutting down its entire position in nano-cap company Savient Pharmaceuticals Inc (OTCMKTS:SVNTQ).

If you were to ask many traders, hedge funds are viewed as useless, outdated financial tools of a forgotten age.

In today’s marketplace, there are a multitude of methods shareholders can use to watch stocks. A pair of the most under-the-radar are hedge fund and insider trading activity.

In the 21st century investor’s toolkit, there are tons of metrics shareholders can use to track publicly traded companies.

To say that William Leland Edwards of Palo Alto Investors invest heavily in healthcare stocks would be, well, a bit of an understatement.  The fund’s positions read like a pharmaceutical sales rep’...